MTOR and neoplasm: Similar to the present results, although rapamycin, an inhibitor of mTOR, alone did not induce senescence in the SMMC-7221 hepatocellular carcinoma cell line, its combination with 5-FU, an anti-metabolite, induced senescence and exerted synergistic anti-tumor effects [44].